How to Patent an Idea and Sell It: Why the Order Decides the Deal

File first, then sell. That order is not a preference, it is the only sequence that leaves you with something to sell. A public disclosure or an offer for sale starts a 12-month clock on your U.S. rights and forfeits your foreign rights outright, since Europe, China, and Japan require absolute novelty. Every corporate submission agreement you sign says the company owes you nothing for an unprotected disclosure. And a buyer or licensee prices what they can own, which is the application, not the concept. A provisional application costs $130 to $325 in small entity government fees, and filing it before the first pitch is the cheapest decision in the whole sequence.

Here is the combined path, what you can sell at each stage, and the two orders that cost inventors deals.

Why Filing First Is Not Optional

Four separate mechanisms punish the wrong order.

The grace period is a one-way door. The United States gives you 12 months from your own public disclosure, public use, or offer for sale to file. Miss it and the invention is unpatentable. Nothing cures it. Your own Kickstarter page, trade show booth, or forum post starts the clock.

Foreign rights end at first disclosure. Most of the world applies absolute novelty with no grace period. One public disclosure before filing and the European, Chinese, and Japanese rights are gone permanently. If the licensee sells internationally, that matters to the value of what you are offering.

Submission agreements are written against you. Every open innovation portal makes you agree that no confidential relationship exists, that the company may already be working on the same thing, and that compensation arises only under a separately signed agreement, usually tied to a pending or issued patent. Read that carefully. It says the disclosure alone earns nothing.

Buyers price ownership, not concepts. A licensing conversation moves from “interesting” to “let us talk terms” when there is an application number. Without one, the company is being asked to pay for information it will receive for free the moment you describe the product.

The Combined Timeline

The overlap is the point. Months 3 through 11 are simultaneously the patent-pending window and the selling window, and inventors who treat them as sequential stages lose a year. The full calendar with the branch points is in the patent timeline month by month, and the USPTO patent process overview sets out what the office does at each stage.

What You Can Sell at Each Stage

Patent rights are property from the day the application is filed. What changes across stages is how much certainty the buyer has, and certainty is what they pay for.

Most independent inventor license deals close during the pending stages, not after issuance. Waiting for a patent to issue before pitching adds two to four years to the calendar and burns a meaningful share of the 20-year term while the product sits on a shelf. What patent pending does and does not give you is spelled out in what patent pending means.

The Two Orders That Cost People Deals

Selling first, filing later. The inventor pitches five companies, one shows interest, and only then does the filing conversation start. By that point the disclosure clock is running, foreign rights are gone, and the interested company knows there is nothing on file. The negotiating position collapsed before it existed.

Waiting for issuance before pitching. The inventor files, waits three years, receives a patent, and then starts contacting companies. Three years of term are gone, the category may have moved, and the competitor who launched something adjacent in year two now owns the shelf space. Issuance is not a prerequisite for a license. It is a milestone that improves terms, and it can happen while the licensee is already selling.

The correct order runs both processes at once: file, then pitch during the pendency, with the conversion decision informed by whatever the pitching produced.

Using the 12 Months Properly

The provisional year returns more per dollar than any other stretch in the sequence, because it is the only period where you can disclose without risk and still have not committed the large money.

Four things belong in it:

1. Prototype iteration. Three to seven versions is the normal band. Each one should answer a question you wrote down first.
2. Landed cost work. Companies evaluate against their margin structure. A cost estimate is what turns “interesting” into “let us look at it.”
3. Parallel submissions. Portals and named contacts at the same time. The mechanics of the submission and what the agreement obligates are covered in how to sell an idea to a company.
4. Claim development. Everything you learn in months 3 through 11 about how the product will be built should shape the claims in the conversion. That is the strongest argument for filing the provisional yourself and paying for professional drafting at conversion, when you know more.

At month 11 you have a real decision. Convert at full cost, let it lapse and stop, or convert with a licensee who has agreed to fund prosecution. The third option exists more often than inventors expect, and it is a normal term in an option agreement.

Assignment or License

Two ways to be paid, with different mechanics.

Assignment transfers ownership. You are paid once and the buyer takes the patent. The assignment should be recorded with the USPTO, which protects the buyer against a later purchaser and puts the transfer in the public record. Recording within three months of execution is the practical standard.

License keeps the patent in your name and grants the company the right to practice it in exchange for royalties. Consumer housewares deals commonly land at 3% to 7% of net sales, tools and hardware at 3% to 6%. The rate matters less than three other terms: how net sales is defined, what the minimum annual payments are, and what happens if the licensee stops selling. The step-by-step version of how these deals get built is in the patent licensing process.

Exclusivity is the variable that moves price in both structures. An exclusive license commands better terms and it removes every other counterparty from your board, so it should carry performance minimums and a termination right if the licensee goes quiet.

If representation is the gap, contingency-based licensing representation exists for exactly this stage, where the application is filed and the product needs to reach companies that will take the call.

What a Buyer Diligences

Before any real money moves, expect them to check:

• Chain of title. Every inventor named, every assignment executed and recorded. A co-inventor who never signed is a deal-stopper, and it surfaces in diligence rather than before.
• Prior art. They will run their own search. If they find something your search missed, the terms move or the deal ends.
• Claim scope against their product plan. Does the claim cover what they intend to sell, or only the embodiment you built?
• Prosecution history. Narrowing amendments limit what you can assert later, and buyers read the file wrapper.
• Employment overlap. Did you develop this while employed somewhere with an invention assignment clause? That question ends more deals than prior art does.

Handle the first and the last before you pitch. Both are free to fix in advance and expensive to fix in the middle of a negotiation.

What the Combined Path Costs

Utility patents run $8,000 to $20,000 through issuance at moderate complexity, and the USPTO utility application requirements explain what that money is buying. The cheapest legitimate entry to the whole sequence is a $399 patent search followed by a provisional filing, which together put you in a position to pitch for under $2,000.

FAQ

Can I sell a patent before it is granted?

Yes. A pending application is property and can be assigned or licensed at any point after filing. Buyers discount for the uncertainty, since the claims are not final, so terms typically improve after a notice of allowance. Most independent inventor deals close during pendency rather than after issuance, because waiting burns patent term without improving your position.

How long after filing can I start showing companies?

The day the application is filed. Patent pending status begins at filing, and that is the point of filing first. Nothing requires you to wait for publication, examination, or issuance before pitching.

What is my patent worth?

It depends on the claim scope, the size of the market the claim covers, how easy it is to design around, and whether the licensee has to have it. There is no formula that produces a number from the patent alone. The approaches used to build a defensible figure are in how to value a patent before licensing it. Anyone quoting a valuation without asking about claim scope and market data is guessing.

Should I sell the patent outright or license it?

License, in most independent inventor cases, because the royalty tracks the product’s performance and the patent returns to you if the licensee stops selling. Assignment fits when you want a clean exit, when the buyer requires full ownership to invest, or when the product has a short life cycle that makes a single payment cleaner than a decade of royalty accounting.

What happens if I already showed my idea to a company before filing?

Check the date. If the disclosure was under a year ago, the U.S. grace period is still open and you should file immediately, because it closes on a fixed date. Foreign rights are likely gone. If the disclosure was more than a year ago and it was public, the invention is unpatentable in the United States, and the remaining protections are trademark on the brand, trade secret on anything not disclosed, and speed to market.